G. Mangold
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Co-authors
- Daniel D. Von Hoff (9 shared papers)Daniel L. Dexter (6 shared papers)Helen M. Burt (2 shared papers)Xichen Zhang (2 shared papers)William L. Hunter (2 shared papers)Shelly Gunn (2 shared papers)Toshio Shimizu (1 shared paper)Brianne Kaiser (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Hormone and Metabolic Research (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
G. Mangold
43 papers receiving 1.1k citations
G. Mangold's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 372
- Biomaterials 136
- Molecular Biology 582
- Cancer Research 107
- Pharmaceutical Science 42
Countries citing papers authored by G. Mangold
This map shows the geographic impact of G. Mangold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Mangold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Mangold more than expected).
Fields of papers citing papers by G. Mangold
This network shows the impact of papers produced by G. Mangold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Mangold. The network helps show where G. Mangold may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Mangold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer Hit paper breakdown → | 2012 | 355 |
| 2 | Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. | 1992 | 98 |
| 3 | 1997 | 95 | |
| 4 | Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S. | 1997 | 92 |
| 5 | 1997 | 91 | |
| 6 | Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model. | 1999 | 61 |
| 7 | Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. | 1998 | 59 |
| 8 | 2002 | 34 | |
| 9 | 1998 | 30 | |
| 10 | 2000 | 26 | |
| 11 | Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment. | 1998 | 26 |
| 12 | Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts. | 1999 | 21 |
| 13 | 1999 | 19 | |
| 14 | 2000 | 19 | |
| 15 | 1999 | 16 | |
| 16 | 2004 | 16 | |
| 17 | 1975 | 16 | |
| 18 | Molecular determinants of differential sensitivity to docetaxel and paclitaxel in human pediatric cancer models. | 2006 | 15 |
| 19 | 1977 | 13 | |
| 20 | 2002 | 12 |
About G. Mangold
G. Mangold is a scholar working on Surgery, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (12 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer Diagnosis and Treatment (3 papers), Gastrointestinal disorders and treatments (3 papers), Abdominal Trauma and Injuries (3 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Oncology (372 citations), Biomaterials (136 citations), Molecular Biology (582 citations), Cancer Research (107 citations) and Pharmaceutical Science (42 citations). G. Mangold has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Daniel D. Von Hoff, Daniel L. Dexter, Helen M. Burt, Xichen Zhang, William L. Hunter, Shelly Gunn, Toshio Shimizu, Brianne Kaiser, Amita Patnaik and Cathy Alvarez. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Clinical Cancer Research and Hormone and Metabolic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.